# Propofol Versus Midazolam as Premedication for Preterm Neonates With Respiratory Distress Syndrome (RDS)

> **NCT00797160** · PHASE4 · UNKNOWN · sponsor: **Federal University of Minas Gerais** · enrollment: 20 (estimated)

## Conditions studied

- Respiratory Distress Syndrome

## Interventions

- **DRUG:** propofol

## Key facts

- **NCT ID:** NCT00797160
- **Lead sponsor:** Federal University of Minas Gerais
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-08
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2008-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00797160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00797160, "Propofol Versus Midazolam as Premedication for Preterm Neonates With Respiratory Distress Syndrome (RDS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00797160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*